Migco Pharmaceuticals

Developing drug for migraine headache

placeRangiora, Canterbury, New Zealand calendar_todayFounded 2003 language migco.co.nz

Registered entities

Investor mix

10 investors on record; lead investors include Movac, New Zealand Growth Capital Partners.

Investor typeCountShare
Venture capital550%
Other / undisclosed550%
Coming soon